tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)

C184H127Ir5N19O5-10 — CID 158457746

IUPACtris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)
SMILESCc1cccc(C)c1-n1c(-c2[c-]cccc2)nc2ccccc21.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.[Ir].[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(oc3ccccc32)c1-c1ccccn1.[c-]1ccc2c(oc3ccccc32)c1-c1ccccn1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1
InChIInChI=1S/C21H17N2.3C19H14NO.4C18H12N3.2C17H10NO.5Ir/c1-15-9-8-10-16(2)20(15)23-19-14-7-6-13-18(19)22-21(23)17-11-4-3-5-12-17;3*1-12-10-17(20-11-13(12)2)16-8-5-7-15-14-6-3-4-9-18(14)21-19(15)16;4*1-2-6-14(7-3-1)18-20-16-8-4-5-9-17(16)21(18)15-10-12-19-13-11-15;2*1-2-10-16-12(6-1)13-7-5-8-14(17(13)19-16)15-9-3-4-11-18-15;;;;;/h3-11,13-14H,1-2H3;3*3-7,9-11H,1-2H3;4*1-6,8-13H;2*1-7,9-11H;;;;;/q10*-1;;;;;
InChIKeyBNQDUENEIHXQGA-UHFFFAOYSA-N
MW3645.25 g/mol
LogP44.74
Rot. Bonds15

About tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)

tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole) (PubChem CID 158457746) has the molecular formula C184H127Ir5N19O5-10 and a molecular weight of 3645.25 g/mol. Its IUPAC name is tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole).

Molecular Properties

Compound Nametris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)
PubChem CID158457746
Molecular FormulaC184H127Ir5N19O5-10
Molecular Weight3645.25 g/mol
Exact Mass3646.85
IUPAC Nametris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)
SMILESCc1cccc(C)c1-n1c(-c2[c-]cccc2)nc2ccccc21.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.[Ir].[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(oc3ccccc32)c1-c1ccccn1.[c-]1ccc2c(oc3ccccc32)c1-c1ccccn1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1
InChIInChI=1S/C21H17N2.3C19H14NO.4C18H12N3.2C17H10NO.5Ir/c1-15-9-8-10-16(2)20(15)23-19-14-7-6-13-18(19)22-21(23)17-11-4-3-5-12-17;3*1-12-10-17(20-11-13(12)2)16-8-5-7-15-14-6-3-4-9-18(14)21-19(15)16;4*1-2-6-14(7-3-1)18-20-16-8-4-5-9-17(16)21(18)15-10-12-19-13-11-15;2*1-2-10-16-12(6-1)13-7-5-8-14(17(13)19-16)15-9-3-4-11-18-15;;;;;/h3-11,13-14H,1-2H3;3*3-7,9-11H,1-2H3;4*1-6,8-13H;2*1-7,9-11H;;;;;/q10*-1;;;;;
InChIKeyBNQDUENEIHXQGA-UHFFFAOYSA-N
XLogP44.74
TPSA270.81 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds15
Heavy Atoms213
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003645.25
LogP ≤ 544.74
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)?
The IUPAC name of tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole) (CID 158457746) is tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole).
What is the SMILES notation for tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)?
The canonical SMILES for tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole) is Cc1cccc(C)c1-n1c(-c2[c-]cccc2)nc2ccccc21.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.Cc1cnc(-c2[c-]ccc3c2oc2ccccc23)cc1C.[Ir].[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(oc3ccccc32)c1-c1ccccn1.[c-]1ccc2c(oc3ccccc32)c1-c1ccccn1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.[c-]1ccccc1-c1nc2ccccc2n1-c1ccncc1.
What is the InChIKey of tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)?
The InChIKey is BNQDUENEIHXQGA-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H17N2.3C19H14NO.4C18H12N3.2C17H10NO.5Ir/c1-15-9-8-10-16(2)20(15)23-19-14-7-6-13-18(19)22-21(23)17-11-4-3-5-12-17;3*1-12-10-17(20-11-13(12)2)16-8-5-7-15-14-6-3-4-9-18(14)21-19(15)16;4*1-2-6-14(7-3-1)18-20-16-8-4-5-9-17(16)21(18)15-10-12-19-13-11-15;2*1-2-10-16-12(6-1)13-7-5-8-14(17(13)19-16)15-9-3-4-11-18-15;;;;;/h3-11,13-14H,1-2H3;3*3-7,9-11H,1-2H3;4*1-6,8-13H;2*1-7,9-11H;;;;;/q10*-1;;;;;.
What are the key properties of tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole)?
tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole) has a molecular weight of 3645.25 g/mol, XLogP of 44.74, 15 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for tris(2-(3H-dibenzofuran-3-id-4-yl)-4,5-dimethylpyridine);bis(2-(3H-dibenzofuran-3-id-4-yl)pyridine);1-(2,6-dimethylphenyl)-2-phenylbenzimidazole;pentakis(iridium);tetrakis(2-phenyl-1-pyridin-4-ylbenzimidazole) is sourced from PubChem (CID 158457746), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).